Triacetylresveratrol (CAS 42206-94-0)

Triacetylresveratrol, a derivative of the well-known polyphenolic compound resveratrol, has garnered attention in scientific research for its potential biological activities and implications. Its mechanism of action involves modulation of various cellular pathways associated with inflammation, oxidative stress, and aging. Specifically, triacetylresveratrol exerts its effects by activating sirtuin enzymes, particularly SIRT1, which are implicated in regulating cellular metabolism, DNA repair, and longevity. Research investigations have demonstrated the ability of triacetylresveratrol to enhance sirtuin activity, leading to downstream effects such as improved mitochondrial function, increased antioxidant defenses, and enhanced stress resistance. Additionally, triacetylresveratrol has been explored for its potential anti-inflammatory properties, with studies indicating its ability to suppress pro-inflammatory cytokine production and inhibit NF-κB signaling. Moreover, triacetylresveratrol shows promise in modulating cellular senescence pathways, offering potential avenues for interventions in age-related diseases. Beyond its direct effects on cellular pathways, triacetylresveratrol has been investigated for its potential applications in various research areas, including aging biology, metabolic disorders, neurodegenerative diseases, and cancer. Its multifaceted mechanism of action and diverse research applications underscore triacetylresveratrol′s significance as a valuable tool for advancing our understanding of cellular physiology and exploring novel strategies.